Cargando…

The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs

BACKGROUND: Serious infections in persons who use drugs (PWUD) are rising. Dalbavancin, due to its extended half-life, offers an alternative treatment for patients in whom standard of care antibiotics are not feasible or practical, allowing for reduced hospital days and the avoidance of central line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglass, Alyse H., Mayer, Heather, Young, Kathleen, Sikka, Monica K., Strnad, Luke, Makadia, Jina, Sukerman, Ellie, Lewis, James S., Streifel, Amber C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Outpatient Parenteral Antimicrobial Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423448/ https://www.ncbi.nlm.nih.gov/pubmed/37581105 http://dx.doi.org/10.1177/20499361231189405

Ejemplares similares

625. The Hidden Cost of Dalbavancin: OPAT-RN Time Spent on Coordination for Patients with Substance Use Disorder
por: Douglass, Alyse, et al.
Publicado: (2021)

Facilitating OPAT in rural areas
por: Mehta, Meera, et al.
Publicado: (2023)

Exploring the advancements of Australian OPAT
por: Lai, Tony, et al.
Publicado: (2023)

From sea to shining IV: the current state of OPAT in the United States
por: Larnard, Jeffrey, et al.
Publicado: (2023)

A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion
por: Van Abel, Amy L., et al.
Publicado: (2023)

Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort
por: Billmeyer, Kaylyn N., et al.
Publicado: (2023)

What is the role of the clinical microbiology laboratory in the care of diagnostically challenging OPAT patients? Illustrative cases and literature review
por: Nori, Priya, et al.
Publicado: (2023)

122. Dalbavancin Use in Patients with Substance Use Disorders
por: Streifel, Amber C, et al.
Publicado: (2020)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

Identifying the potential impact of a multidisciplinary outpatient antimicrobial therapy program in an area of high social vulnerability
por: Tan, Karen K., et al.
Publicado: (2023)

Retrospective analysis of the management of pelvic decubitus ulcers and their outcomes
por: Damioli, Laura, et al.
Publicado: (2023)

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
por: Bradley, Abby C., et al.
Publicado: (2023)

Comparative renal risk of long-term use of beta-lactams in combination with vancomycin across the continuum of care
por: Dolly, Lauren M., et al.
Publicado: (2023)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

Taking the route less traveled: on the way to COpAT
por: Pertzborn, Margaret, et al.
Publicado: (2023)

1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
por: Douglass, Alyse H, et al.
Publicado: (2022)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

1028. Dalbavancin Use in Complicated Infections and-associated Cost-Savings
por: Streifel, Amber C, et al.
Publicado: (2019)

1004. Dalbavancin Use and Associated Cost-Savings: An Update
por: Streifel, Amber C, et al.
Publicado: (2022)

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients
por: Carrothers, Timothy J., et al.
Publicado: (2022)

The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections
por: Giorgobiani, Manana, et al.
Publicado: (2022)

Benefits of quitting smoking on work productivity and activity impairment in the United States, the European Union and China
por: Baker, Christine L., et al.
Publicado: (2017)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

General Principles of Antimicrobial Therapy
por: Leekha, Surbhi, et al.
Publicado: (2011)

Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
por: Razonable, Raymund R.
Publicado: (2011)

Omadacycline Enters the Ring: A New Antimicrobial Contender
por: Barber, Katie E., et al.
Publicado: (2018)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

First identification of bla (NDM-5) producing Escherichia coli from neonates and a HIV infected adult in Tanzania
por: Manyahi, Joel, et al.
Publicado: (2022)

531 Utilization of a Nurse Care Coordinator to Streamline the Outpatient Experience
por: Neal, Joya, et al.
Publicado: (2023)

1829. Dalbavancin versus standard of care as directed therapy for Staphylococcus aureus bacteremia in patients unable to receive OPAT
por: Frazier, J, et al.
Publicado: (2022)

Nutrición enteral y parenteral
Publicado: (1993)

Endonutrición : estado del arte en nutrición clínica /
Publicado: (2007)

Endonutrición : apoyo nutricio /
Publicado: (2013)

742. The Development, Implementation, and Feasibility of Multidisciplinary Treatment Planning Conference for Individuals with Unstable Substance Use Disorders and Active Infections Requiring Prolonged Antimicrobial Therapy: The OPTIONS-DC Model
por: Strnad, Luke, et al.
Publicado: (2019)

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece
por: Galani, Irene, et al.
Publicado: (2012)

Micafungin in Premature and Non-premature Infants: A Systematic Review of 9 Clinical Trials
por: Manzoni, Paolo, et al.
Publicado: (2014)

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
por: Domachowske, Joseph B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nfk609jkvv81gfnecjq221khav